 |
 |
|
|
|
| Stanozolol (Winstrol) |
 |
| 17-methyl-2h-5alpha-androst-2-eno[3,2-c]pyrazol-17beta-ol |
 |
| 10418-03-8 |
 |
Usage: For chronic wasting disease, illness and surgery frail thin, frail, osteoporosis, stunted children, aplastic anemia, etc.
|
 |
Appearance: White or almost white crystalline powder, odorless. Almost insoluble in water, soluble in alcohol, chloroform, slightly soluble in acetone
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
